CHRNChronoScale Corporation

$18.55+320% 1Y

Is the business good?

Watch

More warning than reassurance: 3 of 9 health tests passed and margins compressing.

2 to watch, 2 without data
Fundamental health (F-score)3 / 9SEC EDGAR · May 31, 2026

Weak, deteriorating fundamentals. Nine pass/fail tests of year-over-year health from the filings.

Margin direction, 3 years−48.2 ptsderived

Operating margin has narrowed over the past few years, profitability per dollar of sales is eroding.

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is CHRN?

ChronoScale Corporation keeps −134% of every revenue dollar as operating profit, against 8.0% for the median Information Technology Services name.

−134%

Operating margin · Information Technology Services median 8.0% · 12 months to Q3 2026

R&D as % of revenue
23%

R&D as % of revenue

Gross margin
53%

Gross margin

Operating margin by fiscal year
YearOperating margin
FY2020−150%
FY2021−123%
FY2022−120%
FY2023−83%
FY2024−58%
FY2026−52%
Details›
Gross margin12 months to Q3 2026
53%
Operating margin12 months to Q3 2026
−134%
Net margin12 months to Q3 2026
−136%
Free cash flow margin
−105%
R&D as % of revenue
23%
Revenue, trailing twelve months
$12M
Free cash flow, trailing twelve months
−$12M
Net income, trailing twelve months
−$16M

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.